CHRONIC NICOTINE TREATMENT COUNTERACTS NIGRAL CELL LOSS INDUCED BY A PARTIAL MESODIENCEPHALIC HEMITRANSECTION - AN ANALYSIS OF THE TOTAL NUMBER AND MEAN VOLUME OF NEURONS AND GLIA IN SUBSTANTIA-NIGRA OF THE MALE-RAT
Am. Janson et A. Moller, CHRONIC NICOTINE TREATMENT COUNTERACTS NIGRAL CELL LOSS INDUCED BY A PARTIAL MESODIENCEPHALIC HEMITRANSECTION - AN ANALYSIS OF THE TOTAL NUMBER AND MEAN VOLUME OF NEURONS AND GLIA IN SUBSTANTIA-NIGRA OF THE MALE-RAT, Neuroscience, 57(4), 1993, pp. 931-941
This study combines immunocytochemical and stereological methods for t
he first time to obtain unbiased estimates of the number of cells in t
he entire substantia nigra and their respective mean volume. Nicotine,
delivered by subcutaneously implanted osmotic pumps (0.125 mg/kg/h, 1
4 days) to male Sprague-Dawley rats with a partial unilateral mesodien
cephalic lesion, caused a significant counteraction of the lesion-indu
ced reduction in total number of nigral tyrosine hydroxylase-like immu
noreactive neurons counterstained with Cresyl Violet compared with sal
ine treated control animals. The number of Nissl stained neurons witho
ut tyrosine hydroxylase-like immunoreactivity was not affected by the
lesion nor by nicotine. The numbers of non-neuronal glial fibrillary a
cidic protein-like immunoreactive cells counterstained with Cresyl Vio
let and smaller cells seen after Cresyl Violet staining alone, possibl
y representing microglia, were increased by the lesion but not affecte
d by nicotine. No nicotine-induced effects were found on the number of
nigral cells located contralateral to the lesion. The lesion-induced
reduction in the mean volume of the nigral cells showing tyrosine hydr
oxylase-like immunoreactivity, as determined with the stereological ro
tator method, was not affected by nicotine. These findings suggest tha
t continuous nicotine infusion exerts protective effects on lesioned n
igroneostriatal dopamine systems and that these protective effects are
selective for the nigral dopamine neurons not affecting other populat
ions of neurons or non-neuronal cells. This neuroprotective effect mig
ht lead to new therapeutic strategies in clinical neurodegenerative di
sorders such as Parkinson's Disease.